DuPont de Nemours (NYSE:DD) Given New $173.00 Price Target at Royal Bank Of Canada

Key Points

• Royal Bank of Canada raised DuPont’s price target to $173 from $160 and maintained an “outperform” rating, implying 18.65% upside from the stock’s current price.
• Analyst views are mixed but lean positive: 12 analysts rate the stock Buy, five Hold, and one Sell, for a consensus “Moderate Buy” rating and an average target of $165.88.
• DuPont beat quarterly earnings and revenue expectations, reporting EPS of $2.09 versus $1.87 expected and year-over-year revenue growth of 4.1%; shares nevertheless fell 3.3% on Thursday to $145.80.

DuPont de Nemours (NYSE:DD - Get Free Report) had its target price raised by Royal Bank Of Canada from $160.00 to $173.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has an "outperform" rating on the basic materials company's stock. Royal Bank Of Canada's target price points to a potential upside of 18.65% from the stock's current price.

A number of other brokerages have also recently issued reports on DD. UBS Group lifted their price target on shares of DuPont de Nemours from $172.00 to $182.00 and gave the company a "buy" rating in a research report on Wednesday. The Goldman Sachs Group cut their price objective on shares of DuPont de Nemours from $159.00 to $153.00 and set a "neutral" rating on the stock in a report on Wednesday, September 30th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of DuPont de Nemours in a research note on Friday, October 30th. Barclays raised their price objective on DuPont de Nemours from $156.00 to $176.00 and gave the company an "overweight" rating in a research report on Wednesday. Finally, JPMorgan Chase & Co. downgraded DuPont de Nemours from an "overweight" rating to a "neutral" rating and dropped their target price for the stock from $172.00 to $145.00 in a report on Friday, October 9th. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $165.88.

DuPont de Nemours Trading Down 3.3%

Shares of DD traded down $4.93 during mid-day trading on Thursday, hitting $145.80. 991,607 shares of the company's stock traded hands, compared to its average volume of 1,348,562. The company has a quick ratio of 1.82, a current ratio of 2.36 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $19.69 billion, a P/E ratio of 65.25, a PEG ratio of 1.37 and a beta of 1.06. The business's 50-day moving average price is $132.93 and its 200-day moving average price is $138.62. DuPont de Nemours has a 1 year low of $111.15 and a 1 year high of $157.98.

DuPont de Nemours (NYSE:DD - Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.22. DuPont de Nemours had a return on equity of 6.85% and a net margin of 4.26%. The business had revenue of $1.87 billion for the quarter, compared to analysts' expectations of $1.84 billion. During the same period in the previous year, the firm posted $1.09 EPS. The business's revenue was up 4.1% on a year-over-year basis. As a group, sell-side analysts forecast that DuPont de Nemours will post 7.49 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. State Street Corp increased its holdings in DuPont de Nemours by 140.3% in the 2nd quarter. State Street Corp now owns 44,941,824 shares of the basic materials company's stock worth $6,095,909,000 after acquiring an additional 26,238,300 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of DuPont de Nemours by 22.0% during the first quarter. Bank of America Corp DE now owns 4,629,671 shares of the basic materials company's stock valued at $212,039,000 after acquiring an additional 835,572 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of DuPont de Nemours by 10.0% in the first quarter. Bank of New York Mellon Corp now owns 3,706,596 shares of the basic materials company's stock valued at $169,762,000 after acquiring an additional 336,780 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of DuPont de Nemours by 4.9% in the first quarter. Dimensional Fund Advisors LP now owns 3,509,831 shares of the basic materials company's stock valued at $160,688,000 after acquiring an additional 163,210 shares in the last quarter. Finally, Amundi lifted its position in shares of DuPont de Nemours by 31.3% in the first quarter. Amundi now owns 2,478,630 shares of the basic materials company's stock valued at $113,526,000 after acquiring an additional 591,011 shares in the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.

DuPont de Nemours News Roundup

Here are the key news stories impacting DuPont de Nemours this week:

• Positive Sentiment: DuPont reported third-quarter earnings and revenue above analyst expectations, with revenue up year over year, and raised its 2026 outlook. The earnings beat and improved guidance are key signs of stronger performance. DuPont rises as earnings beat estimates, company raises outlook
• Positive Sentiment: Several firms lifted their price targets and maintained bullish ratings: Wells Fargo to $170 (Overweight), UBS to $182 (Buy), Citigroup to $176 (Buy), and Barclays to $176 (Overweight). These revisions signal increased analyst confidence in DD’s outlook. Wells Fargo price target
• Neutral Sentiment: DuPont’s new peptide purification product may offer an opportunity in biopharmaceutical applications, though the article does not specify its likely near-term financial contribution. DuPont peptide purification product
• Neutral Sentiment: The recent coverage is predominantly upbeat and provides no clear explanation for the latest share-price weakness; profit-taking after the earnings-driven rally is one possible explanation, but is not confirmed by the reports.

DuPont de Nemours Company Profile

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company's product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.